4//SEC Filing
Murray Christopher K. 4
Accession 0001415889-23-016209
CIK 0001597264other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:11 PM ET
Size
16.4 KB
Accession
0001415889-23-016209
Insider Transaction Report
Form 4
Murray Christopher K.
SVP, Technical Operations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-12-07−5,000→ 13,000 totalExercise: $54.13Exp: 2030-03-01→ Common Stock (5,000 underlying) - Sale
Common Stock
2023-12-07$75.00/sh−5,000$375,000→ 24,495 total - Exercise/Conversion
Common Stock
2023-12-07$54.13/sh+5,000$270,650→ 29,495 total
Footnotes (2)
- [F1]Effected pursuant to a trading plan adopted on June 5, 2023 in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This option was granted on March 1, 2020. This option vested with respect to 1/48th of the shares underlying the option on April 1, 2020 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001718648
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:11 PM ET
- Size
- 16.4 KB